Journal
CLINICS IN PERINATOLOGY
Volume 42, Issue 4, Pages 739-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.clp.2015.08.004
Keywords
Bronchopulmonary dysplasia; Biomarkers; Prognosis; Early diagnosis; Infant; Premature; Systems biology; Pulmonary hypertension
Categories
Funding
- NIH [U01 HL122626, R01 HD067126, R01 HD066982, U10 HD34216]
Ask authors/readers for more resources
The pathogenesis of bronchopulmonary dysplasia (BPD) is multifactorial, and the clinical phenotype of BPD is extremely variable. Several clinical and laboratory biomarkers have been proposed for the early identification of infants at higher risk of BPD and for determination of prognosis of infants with a diagnosis of BPD. The authors review available literature on prediction tools and biomarkers of BPD, using clinical variables and biomarkers based on imaging, lung function measures, and measurements of various analytes in different body fluids that have been determined to be associated with BPD either in a targeted manner or by unbiased omic profiling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available